New treatment options for RLS were unveiled in 2021, including the use of an antiplatelet drug, dipyridamole.
One study showed that after two weeks of treatment, patients experienced marked improvement in symptoms and more regular sleep.
Researchers are also wondering about the role of antacids (stomach) in reducing RLS.
The current treatment of choice, however, remains pregabalin (neuropathies, epilepsy, anxiety).